Zapp2Photo / iStockphoto.com
14 November 2018Americas
IBM patent targets blockchain in open scientific research
Technology company IBM is seeking to patent the use of blockchain in open scientific research, including experiments, data collection, and analysis.
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
Americas
13 February 2019 The Canadian units of IBM and pharmaceutical company Boehringer Ingelheim have united to explore the use of blockchain technology in clinical trials.
Americas
17 June 2019 The US Food and Drug Administration has chosen Merck & Co, IBM, KPMG, and Walmart to form a pilot project aimed at evaluating the use of blockchain to protect pharmaceutical product integrity.
Americas
20 February 2020 US conglomerate 3M has dropped its copyright infringement claim against technology company IBM less than one month after filing suit.
Editor's picks
Editor's picks
Americas
13 February 2019 The Canadian units of IBM and pharmaceutical company Boehringer Ingelheim have united to explore the use of blockchain technology in clinical trials.
Americas
17 June 2019 The US Food and Drug Administration has chosen Merck & Co, IBM, KPMG, and Walmart to form a pilot project aimed at evaluating the use of blockchain to protect pharmaceutical product integrity.
Americas
20 February 2020 US conglomerate 3M has dropped its copyright infringement claim against technology company IBM less than one month after filing suit.
Americas
13 February 2019 The Canadian units of IBM and pharmaceutical company Boehringer Ingelheim have united to explore the use of blockchain technology in clinical trials.
Americas
17 June 2019 The US Food and Drug Administration has chosen Merck & Co, IBM, KPMG, and Walmart to form a pilot project aimed at evaluating the use of blockchain to protect pharmaceutical product integrity.
Americas
20 February 2020 US conglomerate 3M has dropped its copyright infringement claim against technology company IBM less than one month after filing suit.